BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 25982211)

  • 1. Vogt-Koyanagi-Harada disease after stapedotomy.
    Accorinti M; Gilardi M; Nardella C; Amorelli GM; Pesci FR
    Eur J Ophthalmol; 2015 Oct; 25(6):e127-30. PubMed ID: 25982211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vogt-Koyanagi-Harada Syndrome following influenza vaccination.
    Kim M
    Indian J Ophthalmol; 2016 Jan; 64(1):98. PubMed ID: 26953036
    [No Abstract]   [Full Text] [Related]  

  • 3. Bilateral disc edema in a patient with Vogt-Koyanagi-Harada disease.
    Yang HK; Park KH; Kim JS; Hwang JM
    Can J Ophthalmol; 2014 Apr; 49(2):e54-6. PubMed ID: 24767242
    [No Abstract]   [Full Text] [Related]  

  • 4. Vogt-Koyanagi-Harada disease in 3-year-old boy.
    Takada S; Tanaka R; Kurita N; Ishii K; Kaburaki T
    Clin Exp Ophthalmol; 2015 Aug; 43(6):593-4. PubMed ID: 25711345
    [No Abstract]   [Full Text] [Related]  

  • 5. Vogt-Koyanagi-Harada disease after head trauma.
    Accorinti M; Pirraglia MP; Corsi C; Caggiano C
    Eur J Ophthalmol; 2007; 17(5):847-52. PubMed ID: 17932867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis.
    Agarwal A; Freund KB; Kumar A; Aggarwal K; Sharma D; Katoch D; Bansal R; Gupta V;
    Retina; 2021 Apr; 41(4):774-783. PubMed ID: 32833410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
    Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
    Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular brucellosis vs Vogt-Koyanagi-Harada syndrome.
    Goldstein DA; Tessler HH
    Arch Ophthalmol; 2006 Apr; 124(4):608-9; author reply 609. PubMed ID: 16606901
    [No Abstract]   [Full Text] [Related]  

  • 9. Vogt-Koyanagi-Harada syndrome in an 11-year-old Boy.
    Ikeda N; Hayasaka S; Kadoi C; Nagaki Y
    Ophthalmologica; 1999; 213(3):197-9. PubMed ID: 10202295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Vogt-Koyanagi-Harada syndrome in pregnancy.
    Tien MC; Teoh SC
    Can J Ophthalmol; 2009 Apr; 44(2):211-2. PubMed ID: 19491962
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
    Karacorlu M; Arf Karacorlu S; Ozdemir H
    Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
    Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serous Macular Detachment in Probable Vogt-Koyanagi-Harada Syndrome.
    Li AS; Tang PH; Do DV
    JAMA Ophthalmol; 2020 May; 138(5):e191981. PubMed ID: 32407448
    [No Abstract]   [Full Text] [Related]  

  • 14. Vogt-Koyanagi-Harada syndrome in a case of multiple sclerosis.
    Montero JA; Sanchis ME; Fernandez-Munoz M
    J Neuroophthalmol; 2007 Mar; 27(1):36-40. PubMed ID: 17414871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease.
    Maruko I; Iida T; Sugano Y; Oyamada H; Sekiryu T; Fujiwara T; Spaide RF
    Retina; 2011 Mar; 31(3):510-7. PubMed ID: 20948460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
    Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
    BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
    Hashizume K; Imamura Y; Fujiwara T; Machida S; Ishida M; Kurosaka D
    Retina; 2016 Feb; 36(2):415-21. PubMed ID: 26352553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
    Lu S; Taban M
    Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome.
    Chew SK; Levy J; Rogers S; Lim LL
    Am J Ophthalmol; 2016 Jul; 167():52-6. PubMed ID: 27066721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vogt-Koyanagi-Harada syndrome in a 4-year-old child.
    Gruich MJ; Evans OB; Storey JM; Bradley ST; Chen CJ
    Pediatr Neurol; 1995 Jul; 13(1):50-1. PubMed ID: 7575849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.